BACKGROUND: Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination there is significant variability between individuals in protective antibody levels against SARS-CoV-2, and within individuals against different virus variants. However, host demographic or clinical characteristics that predict variability in cross-reactive antibody levels are not well-described. These data could inform clinicians, researchers, and policymakers on the populations most likely to require vaccine booster shots. METHODS: In an institutional review board-approved prospective observational cohort study of staff at St. Jude Childrens Research Hospital, we identified participants with plasma samples collected after SARS-CoV-2 ...
Background: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in ...
International audienceUnderstanding the immune responses elicited by SARS-CoV-2 infection is critica...
Background: Heterogeneity of the population in relation to infection, COVID-19 vaccination, and host...
Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding...
Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding...
Understanding vaccine-mediated protection against severe acute respiratory syndrome coronavirus-2 (S...
COVID-19 is a current global threat, and the characterization of antibody response is vitally import...
BackgroundReports suggest that some persons previously infected with severe acute respiratory syndro...
Understanding the trajectory, duration, and determinants of antibody responses after SARS-CoV-2 infe...
Background: Currently, evaluation of the IgG antibodies specific for the SARS-CoV-2 Spike protein fo...
Abstract SARS-CoV-2 variants of concern (VOCs) have emerged worldwide, with implications on the spre...
Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data regarding the indi...
We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange County, CA., b...
Abstract We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange Count...
The duration and nature of immunity generated in response to SARS-CoV-2 infection is unknown. Many p...
Background: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in ...
International audienceUnderstanding the immune responses elicited by SARS-CoV-2 infection is critica...
Background: Heterogeneity of the population in relation to infection, COVID-19 vaccination, and host...
Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding...
Introduction: Higher antibody levels, in particular antibodies directed against the receptor-binding...
Understanding vaccine-mediated protection against severe acute respiratory syndrome coronavirus-2 (S...
COVID-19 is a current global threat, and the characterization of antibody response is vitally import...
BackgroundReports suggest that some persons previously infected with severe acute respiratory syndro...
Understanding the trajectory, duration, and determinants of antibody responses after SARS-CoV-2 infe...
Background: Currently, evaluation of the IgG antibodies specific for the SARS-CoV-2 Spike protein fo...
Abstract SARS-CoV-2 variants of concern (VOCs) have emerged worldwide, with implications on the spre...
Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data regarding the indi...
We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange County, CA., b...
Abstract We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange Count...
The duration and nature of immunity generated in response to SARS-CoV-2 infection is unknown. Many p...
Background: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in ...
International audienceUnderstanding the immune responses elicited by SARS-CoV-2 infection is critica...
Background: Heterogeneity of the population in relation to infection, COVID-19 vaccination, and host...